Discover 2,272 paid clinical trials in Berkeley, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,272
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: San Francisco CA, Los Angeles CA, Fullerton CA,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06203210
Phase3, Recruiting
EyeConic: Qualification for Cone-Optogenetics
for
Retinal Dystrophies
Location: San Francisco CA, Pittsburgh PA, Miami FL
Sponsor: Institute of Molecular and Clinical Ophthalmology Basel
Sex: All
Age: 0+
Code: NCT05294978
Recruiting
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Location: San Francisco CA, Columbus OH, Gainesville FL,
Sponsor: Duke University
Sex: All
Age: 2 - 21
Code: NCT06654882
Phase3, Recruiting
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
for
Breast Cancer
Location: San Francisco CA, Redding CA, Bakersfield CA,
Sponsor: Agendia
Sex: All
Age: 18+
Code: NCT03053193
Recruiting
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
for
Recurrent Childhood Acute Myeloid Leukemia,
Location: San Francisco CA, Orange CA, Aurora CO, Minneapolis MN,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 18
Code: NCT06247787
Phase1, Recruiting
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
Location: San Francisco CA, Los Angeles CA, Orange CA, Aurora CO,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT04851119
Phase1, Phase2, Recruiting
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
for
Breast Cancer, Solid Tumors, Adult
Location: San Francisco CA, Los Angeles CA, Portland OR,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05768139
Phase1, Phase2, Recruiting
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
for
Locally Advanced or Metastatic ER+ HER2- Breast Cancer,
Location: San Francisco CA, Los Angeles CA, Seattle WA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT04606446
Phase2, Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: San Francisco CA, Walnut Creek CA, Eugene OR,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06824467
Phase3, Recruiting
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
for
Solid Tumor
Location: San Francisco CA, Los Angeles CA, Duarte CA, Irvine CA,